PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 5, 2026Saudi Medical Journal3 citationsOpen Access

National Heart Center/Saudi Heart Association 2025 Guidelines for Cardiovascular Diseases Prevention and Risk Assessment

JAJamilah AlRahimiSSShukri Al SaifLHLaith Hussain-Alkhateeb

Key Result

The 2025 NHC/SHA guidelines provide an updated, evidence-based framework for primary and secondary cardiovascular disease prevention tailored to the Saudi population.

Key Points

  • This guideline aims to provide a framework for preventing cardiovascular diseases (CVDs) in the Saudi population through lifestyle and medication strategies.
  • Developed evidence-based guidelines
  • Focused on the Saudi population
  • Emphasized prevention and lifestyle modifications
  • Outlined optimized pharmacologic management strategies
  • Offers a comprehensive approach to reducing CVD burden
  • Encourages lifestyle changes among the Saudi population
  • Highlights the importance of medication management

Structured PICO

P
Population
11,381 persons 15 years of age and older from a nationally representative household survey in the Kingdom of Saudi Arabia
O
Outcome
Prevalence of tobacco use (smoking and smokeless), cessation, secondhand smoke exposure, economics, media, and knowledge, attitudes and perceptions towards tobacco use

The 2019 Global Adult Tobacco Survey in Saudi Arabia demonstrates a 19.8% prevalence of tobacco use, with significantly higher rates in men (30.0%) compared to women (4.2%), informing national cardiovascular disease prevention strategies.

Limitations

  • Limited administrative health data in Saudi Arabia makes the true burden of CVD challenging to quantify
  • Specific anthropometric cutoffs for Eastern Mediterranean and Middle Eastern populations remain unavailable due to limited data

Abstract

This guideline presents an updated, evidence-based framework specifically designed for the Saudi population, underscoring prevention, lifestyle modification, and optimized pharmacologic management to address the rising burden of CVDs.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

AlRahimi et al. (2026) conducted a review in Cardiovascular disease. Cardiovascular disease prevention and risk assessment guidelines was evaluated. The 2025 NHC/SHA guidelines provide an updated, evidence-based framework for primary and secondary cardiovascular disease prevention tailored to the Saudi population.

synapsesocial.com/papers/6984348bf1d9ada3c1fb2d0chttps://doi.org/10.15537/smj.2026.47.1.20250578
Ask AI
Helpful
Bookmark
Share
View Full Paper